Nitric Oxide Synthase (NOS) as Therapeutic Target for Asthma and Chronic Obstructive Pulmonary Disease

Publisher： Bentham Science Publishers

E-ISSN： 1873-5592|7|6|721-735

ISSN： 1389-4501

Source： Current Drug Targets, Vol.7, Iss.6, 2006-06, pp. : 721-735

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Histone deacetylase pathway: an evolving therapeutic target in chronic obstructive pulmonary disease

By Antoniu Sabina A  

Expert Opinion on Therapeutic Targets, Vol. 10, Iss. 2, 2006-04 ,pp. : 329-332

Informa Healthcare

Access to resources Recommend Favorite

Editorial (Thematic Issues: Therapeutic Strategies to Target Endothelial Nitric-Oxide Synthase (eNOS))

By  

Current Pharmaceutical Design, Vol. 20, Iss. 22, 2014-05 ,pp. : 3501-3502

Bentham Science Publishers

Access to resources Recommend Favorite

Oxidants in Asthma and in Chronic Obstructive Pulmonary Disease (COPD)

By  

Current Pharmaceutical Design, Vol. 11, Iss. 16, 2005-06 ,pp. : 2053-2062

Bentham Science Publishers

Access to resources Recommend Favorite

Matrix Metalloproteinase-9/Gelatinase B is a Putative Therapeutic Target of Chronic Obstructive Pulmonary Disease and Multiple Sclerosis

By  

Current Pharmaceutical Biotechnology, Vol. 9, Iss. 1, 2008-02 ,pp. : 34-46

Bentham Science Publishers

Access to resources Recommend Favorite

Nitric Oxide: Target for Therapeutic Strategies in Alzheimer's Disease

By  

Current Pharmaceutical Design, Vol. 16, Iss. 25, 2010-08 ,pp. : 2837-2850

Bentham Science Publishers

Access to resources Recommend Favorite